B., Cucchi, D
Noom Med offers 21-day or 30-day trials at reduced rates ($69-$149)
These improvements in cardiometabolic markers alongside lipid panel improvements including reduced triglycerides and LDL cholesterol make retatrutide particularly relevant for researchers studying metabolic syndrome and cardiovascular risk factor reduction
Orally Administered Semaglutide Clinical Data: Summary of PIONEER Trials PIONEER is the phase 3 trial programme of orally administered semaglutide designed to evaluate the riskbenefit profile of orally administered semaglutide
Learn more here about 6 Wegovy side effects you need to be aware of Amphetamine-derivative, stimulant type weight loss drugs may be associated with constipation, dry mouth, restlessness, withdrawal effects, or insomnia (difficulty sleeping), drug abuse and addiction
Researchers took a closer look at the results after the main study was completed, and these findings were shared at a major medical conference (the EASD congress) in September 2025